Mehrdad Hefazi-Torghabeh

17PUBLICATIONS
116CO-AUTHORS
Haematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

|Jun 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

|Apr 06, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients.

Saubia Fathima, Lior Rokach, Nour Ghosoun

|Sep 04, 2025
Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX.

Khalil Hassan, Anmol Baranwal, Al Rabee Kassis

|Jul 29, 2025
Outcomes of Post-Transplant Rh-GCSF and Decitabine Maintenance Therapy in Patients With High-Risk Myeloid Neoplasm.

Mathias Palmer, Anmol Baranwal, Rami Basmaci

|Jun 24, 2025
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes.

Clifford M Csizmar, Anuya Natu, Mark Gurney

Pageof 3

Frequent Collaborators

12 joint publications

Abhishek Mangoankar

12 joint publications

Mithun Vinod Shah

9 joint publications

Mrinal Patnaik

8 joint publications

Antoine Saliba